ARCHIVES

Clinical Research; Duke Received Several Warnings from OPRR, Letters Indicate

This article is from The Cancer Letter archive.

Vol. 25 No. 19 | May 14, 1999

Download PDF Visit The Full Archive

Related Articles

FDA news: Von Eschenbach to FDA staff: “I did not come here to be a figurehead…. While I am here, I will lead.”

November 4, 2005

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011

Report Backs EPA Classification of PERC as Likely Human Carcinogen

February 12, 2010

Oncologists Tell Congress Community Cancer Practices Are Not Adequately Reimbursed

April 4, 2014

Three Genetics Pioneers Win Nobel Prize

October 11, 2002

NCI Posts Website Usability Research, Information Online.

January 12, 2001